EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
1.1.1.51 | (R)-1,2,3,4-tetrahydro-1-naphthol + NAD+ |
i.e. R-tetralol |
Mesocricetus auratus |
3,4-dihydronaphthalen-1(2H)-one + NADH + H+ |
- |
? |
1.1.1.51 | (S)-1,2,3,4-tetrahydro-1-naphthol + NAD+ |
i.e. S-tetralol |
Mesocricetus auratus |
3,4-dihydronaphthalen-1(2H)-one + NADH + H+ |
- |
? |
1.1.1.51 | (S)-1,2,3,4-tetrahydro-1-naphthol + NADP+ |
i.e. S-tetralol |
Mesocricetus auratus |
3,4-dihydronaphthalen-1(2H)-one + NADPH + H+ |
- |
? |
1.1.1.51 | (S)-1-indanol + NAD+ |
- |
Mesocricetus auratus |
2,3-dihydro-1H-inden-1-one + NADH + H+ |
- |
? |
1.1.1.51 | (S)-camphorquinone + NADH + H+ |
- |
Mesocricetus auratus |
? + NAD+ |
- |
? |
1.1.1.51 | (S)-camphorquinone + NADPH + H+ |
- |
Mesocricetus auratus |
? + NADP+ |
- |
? |
1.1.1.51 | 1-acenaphthenol + NAD+ |
- |
Mesocricetus auratus |
acenaphthylen-1(2H)-one + NADH + H+ |
- |
? |
1.1.1.51 | 11beta-hydroxyandrost-5-ene-3,17-dione + NADPH |
i.e. 11beta-hydroxy-androstenedione, reduction at C17 |
Homo sapiens |
11beta,17beta-dihydroxyandrost-5-ene-3-one + NADP+ |
i.e. 11beta-testosterone |
? |
1.1.1.51 | 11beta-hydroxyandrost-5-ene-3,17-dione + NADPH |
i.e. 11beta-hydroxy-androstenedione, reduction at C17 |
Danio rerio |
11beta,17beta-dihydroxyandrost-5-ene-3-one + NADP+ |
i.e. 11beta-testosterone |
? |
1.1.1.51 | 17-oxo steroids + NADPH |
maintenance of balance between oxidized and reduced steroids in blood |
Homo sapiens |
? |
- |
? |